Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Clinical trial NCT00353678 · COMPLETED

Trial details

NCT number: NCT00353678
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 1141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.